Arranta Bio Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Arranta Bio's estimated annual revenue is currently $18.6M per year.
- Arranta Bio's estimated revenue per employee is $155,000
- Arranta Bio has 120 Employees.
- Arranta Bio grew their employee count by 186% last year.
- Arranta Bio currently has 36 job openings.
What Is Arranta Bio?
The Marvelous Microbiome The microbiome ? literally trillions of bacteria, fungi, protozoa and viruses living in and on the human body ? has been called the second genome. Over the last decade, there has been rapid acceleration in scientific understanding of its composition and functions. Today, around 200 companies are focused on understanding the human microbiome and its linkage to areas including infectious diseases and oncology to identify therapeutic targets. Arranta Bio is building a CDMO to support these innovators at the frontier of this exciting new sphere of medicine. Supporting the Pioneers of the Microbiome Arranta Bio is delivering on its vision to build the best-in-class microbiome contract development and manufacturing organization (CDMO) through our merger with a 10-year veteran CDMO, Captozyme, and the establishment of a commercial-ready manufacturing facility. We provide manufacturing and development support for live biotherapeutic products (LBPs) targeting gut health and microbiome-related diseases by providing development and manufacturing services that bring effective treatments to the market and patients in need. Microbiome CDMO Services Arranta Bio offers process development and cGMP manufacture of live biotherapeutic products (LBPs) for clinical and commercial supply. Partner With Us Whether you have a potential solution for the Next Big Thing in the microbiome or are curious about the powerful potential of LBPs, we're eager to hear from you. Contact us today by visiting our website: ArrantaBio.comkeywords:N/A